Standigm announced today that it has launched two AI-driven drug discovery services, Expander and Hunter. Expander is a service that new and better indications for customer’s in-house compounds. By using Expander service, pharmaceutical companies are now able to achieve a quick identification of a novel clinical use for their existing drugs with low cost and effort. Hunter, another service other than Expander, discovers repositioned lead compounds tailored to customer’s interest. Hunter is based on Standigm’s state-of-the-art AI technology and searches for potential drugs, protein targets to combat the specific diseases that our customers are interested in. .
Event BIO-Europe 2017
Date : November 6–8, 2017
Location : Berlin, GermanyJinhan Kim, Standigm CEO will speak at the Bio-Europe 2017 on November 7, 2017. Sang Ok Song, Standigm COO will also attend the meeting. Meet them in Berlin.
Date : January 22-24 , 2018
Location : Silicon Valley, CA, USASang Ok Song, Standigm COO, will attend the PMWC 2018 Silicon Valley and present at the AI company showcase .
Date : February 19-20, 2018
Location : Berlin, GermanyJinhan Kim, Standigm CEO, will be attending Artificial Intelligence in Pharma Industry Summit 2018.